WHO ICTRP trial
Effect of Tadalafil in treatment of Overactive bladder
IRCT2013030212668N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2013030212668N1 |
|---|---|
| Public title | Effect of Tadalafil in treatment of Overactive bladder |
| Scientific title | Comparison of the efficacy of Tadalafil , Toltrodine and Placebo in reduction of symptoms severity of women with Urgency,frequency syndrom / Overactive bladder |
| Primary sponsor | Vice-Research of Medical School of Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | overactive bladder syndrom. Bladder contracted;Bladder contracted |
| Interventions | Intervention 1: Control group: Tolterodine, Tab. 2 mg Oral, q12h for 4 weeks. Intervention 2: Intervention group: Tadalafil, Tab. 20 mg Oral, qod for 4 weeks. Intervention 3: Control group: Placebo(glucose), Tab. 1 Number Oral, qod for 4… |
| Registration date | May 21, 2013 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: